journal article·2021-05-16Open access

EtoGel for Intra-Articular Drug Delivery: A New Challenge for Joint Diseases Treatment

Maria Chiara Cristiano, Antonia Mancuso, Elena Giuliano, Donato Cosco, Donatella Paolino, Massimo Fresta

Abstract

Ethosomes® have been proposed as potential intra-articular drug delivery devices, in order to obtain a longer residence time of the delivered drug in the knee joint. To this aim, the conventional composition and preparation method were modified. Ethosomes® were prepared by using a low ethanol concentration and carrying out a vesicle extrusion during the preparation. The modified composition did not affect the deformability of ethosomes®, a typical feature of this colloidal vesicular topical carrier. The maintenance of sufficient deformability bodes well for an effective ethosome® application in the treatment of joint pathologies because they should be able to go beyond the pores of the dense collagen II network. The investigated ethosomes® were inserted in a three-dimensional network of thermo-sensitive poloxamer gel (EtoGel) to improve the residence time in the joint. Rheological experiments evidenced that EtoGel could allow an easy intra-articular injection at room temperature and hence transform itself in gel form at body temperature into the joint. Furthermore, EtoGel seemed to be able to support the knee joint during walking and running. In vitro studies demonstrated that the amount of used ethanol did not affect the viability of human chondrocytes and nanocarriers were also able to suitably interact with cells.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advancements in Transdermal Drug Delivery · Osteoarthritis Treatment and Mechanisms · Tendon Structure and Treatment

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Experimental and Clinical Medicine, Campus Universitario—Germaneto, “Magna Græcia” University of Catanzaro, Viale Europa, I-88100 Catanzaro, Italy

Department of Health Science, Campus Universitario—Germaneto, “Magna Græcia” University of Catanzaro, Viale Europa, I-88100 Catanzaro, Italy

References (60)

Show source-provided references
1. Intra-articular drug delivery systems for the treatment of rheumatic diseases: A review of the factors influencing their performance10.1016/j.ejpb.2009.06.009 ↗
2. Micro- and Nano-Carrier Mediated Intra-Articular Drug Delivery Systems for the Treatment of Osteoarthritis
3. Biodistribution and clearance of intra-articular liposomes in a large animal model using a radiographic marker10.1080/08982100701557129 ↗
4. Emerging intra-articular drug delivery systems for the temporomandibular joint10.1016/j.ymeth.2008.09.001 ↗
5. Enhancement of chemotherapeutic drug toxicity to human tumour cells in vitro by a subset of non-steroidal anti-inflammatory drugs (NSAIDs)10.1016/S0959-8049(98)00045-8 ↗
6. Non-steroidal anti-inflammatory drugs, including cyclooxygenase-2 inhibitors, in osteoarthritic knee pain: Metaanalysis of randomised placebo controlled trials10.1136/bmj.38273.626655.63 ↗
7. Individual NSAIDs and Upper Gastrointestinal Complications. A Systematic Review and Meta-Analysis of Observational Studies (the SOS Project)10.1007/BF03261999 ↗
8. Biodegradable ibuprofen-loaded PLGA microspheres for intraarticular administration. Effect of Labrafil addition on release in vitro10.1016/j.ijpharm.2004.04.003 ↗
9. An amidated carboxymethylcellulose hydrogel for cartilage regeneration10.1007/s10856-008-3412-7 ↗
10. Liposome-encapsulated fish oil protein-tagged gold nanoparticles for intra-articular therapy in osteoarthritis10.2217/nnm-2018-0221 ↗
11. Drug-fortified liposomes as carriers for sustained release of NSAIDs: The concept and its validation in the animal model for the treatment of arthritis10.1016/j.ejps.2018.09.009 ↗
12. Improved Chondrotoxic Profile of Liposomal Bupivacaine Compared With Standard Bupivacaine After Intra-articular Infiltration in a Porcine Model10.1177/0363546517732558 ↗
13. Etoricoxib-loaded bio-adhesive hybridized polylactic acid-based nanoparticles as an intra-articular injection for the treatment of osteoarthritis10.1016/j.ijpharm.2020.119081 ↗
14. pH-responsive poly(lactide-co-glycolide) nanoparticles containing near-infrared dye for visualization and hyaluronic acid for treatment of osteoarthritis10.1016/j.jconrel.2019.07.031 ↗
15. Intra-articular injection of kartogenin-conjugated polyurethane nanoparticles attenuates the progression of osteoarthritis10.1080/10717544.2018.1461279 ↗
16. Triamcinolone acetonide-loaded PLA/PEG-PDL microparticles for effective intra-articular delivery: Synthesis, optimization, in vitro and in vivo evaluation10.1016/j.jconrel.2019.07.030 ↗
17. Intra-articular TSG-6 delivery from heparin-based microparticles reduces cartilage damage in a rat model of osteoarthritis10.1039/C8BM00010G ↗
18. Synthesis, characterizations, in vitro and in vivo evaluation of Etoricoxib-loaded Poly (Caprolactone) microparticles—A potential Intra-articular drug delivery system for the treatment of Osteoarthritis10.1080/09205063.2015.1125564 ↗
19. Physicochemical properties of extruded and non-extruded liposomes containing the hydrophobic drug dexamethasone10.1016/j.ijpharm.2010.01.003 ↗
20. Liposomes as possible carriers for lactoferrin in the local treatment of inflammatory diseases10.1177/153537020122600608 ↗
21. Preparation and evaluation of biodegradable polymeric systems for the intra-articular delivery of drugs10.1111/j.2042-7158.1984.tb04419.x ↗
22. Studies of pharmacokinetics and therapeutic effects of glucocorticoids entrapped in liposomes after intraarticular application in healthy rabbits and in rabbits with antigen-induced arthritis10.1007/BF00541378 ↗
23. Biofunctional polymer nanoparticles for intra-articular targeting and retention in cartilage10.1038/nmat2116 ↗
24. Hall, B., and Newman, S. (1991). Physicochemical Aspects of Cartilage Extracellular Matrix. Cartilage: Molecular Aspects, CRC Press.
25. Submicron lipid emulsion as a drug delivery system for nalbuphine and its prodrugs10.1016/j.jconrel.2006.07.023 ↗
26. Nanostructured lipid carriers for oral delivery of baicalin: In vitro and in vivo evaluation10.1016/j.colsurfa.2014.11.015 ↗
27. Combination of hyaluronic acid and PLGA particles as hybrid systems for viscosupplementation in osteoarthritis10.1016/j.ijpharm.2019.01.017 ↗
28. Biocompatibility of engineered nanoparticles for drug delivery10.1016/j.jconrel.2012.12.013 ↗
29. Ethosomes—Novel vesicular carriers for enhanced delivery: Characterization and skin penetration properties10.1016/S0168-3659(99)00222-9 ↗
30. In vitro and in vivo trans-epidermal water loss evaluation following topical drug delivery systems application for pharmaceutical analysis10.1016/j.jpba.2020.113295 ↗
31. Drug delivery applications with ethosomes10.1166/jbn.2010.1152 ↗
32. Drug delivery across the skin10.1517/14712598.2.7.723 ↗
33. Cristiano, M.C., Froiio, F., Spaccapelo, R., Mancuso, A., Nisticò, S.P., Udongo, B.P., Fresta, M., and Paolino, D. (2019). Sulforaphane-Loaded Ultradeformable Vesicles as A Potential Natural Nanomedicine for the Treatment of Skin Cancer Diseases. Pharmaceutics, 12.10.3390/pharmaceutics12010006 ↗
34. Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier10.1016/j.jconrel.2003.10.014 ↗
35. Touitou, E. (1996). Compositions for applying active substances to or through the skin. (5540934), U.S. Patent.
36. Cristiano, M.C., Froiio, F., Mancuso, A., de Gaetano, F., Ventura, C.A., Fresta, M., and Paolino, D. (2020). The Rheolaser Master™ and Kinexus rotational rheometer® to evaluate the influence of topical drug delivery systems on rheological features of topical poloxamer gel. Molecules, 25.10.3390/molecules25081979 ↗
37. Turbiscan Lab® Expert analysis of the stability of ethosomes® and ultradeformable liposomes containing a bilayer fluidizing agent10.1016/j.colsurfb.2009.03.007 ↗
38. Fresta, M., Mancuso, A., Cristiano, M.C., Urbanek, K., Cilurzo, F., Cosco, D., Iannone, M., and Paolino, D. (2020). Targeting of the pilosebaceous follicle by liquid crystal nanocarriers: In vitro and in vivo effects of the entrapped minoxidil. Pharmaceutics, 12.10.3390/pharmaceutics12111127 ↗
39. Glycerosomes: A new tool for effective dermal and transdermal drug delivery10.1016/j.ijpharm.2013.07.060 ↗
40. Deformable Surfactant Vesicles Loading Ammonium Glycyrrhizinate: Characterization and In Vitro Permeation Studies10.2174/157018012800389287 ↗
41. Lectin binding studies on C-28/I2 and T/C-28a2 chondrocytes provide a basis for new tissue engineering and drug delivery perspectives in cartilage research10.1016/j.jconrel.2006.10.004 ↗
42. Self-assembled squalenoyl-cytarabine nanostructures as a potent nanomedicine for treatment of leukemic diseases
43. Development of in situ-gelling and mucoadhesive acetaminophen liquid suppository10.1016/S0378-5173(97)00386-4 ↗
44. Gels of Pluronic F127 and nonionic surfactants from rheological characterization to controlled drug permeation10.1016/j.colsurfb.2011.04.033 ↗
45. Effects of sulodexide on stability of sclerosing foams10.1177/0268355518779844 ↗
46. Rheological study of viscosupplements and synovial fluid in patients with osteoarthritis10.5405/jmbe.834 ↗
47. Ethosomes for skin delivery of ammonium glycyrrhizinate: In vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers10.1016/j.jconrel.2005.04.007 ↗
48. Effect of Polydispersity and Charge Heterogeneity on the Depletion Interaction in Colloidal Systems10.1006/jcis.2000.6755 ↗
49. Stability of nanosuspensions in drug delivery10.1016/j.jconrel.2013.08.006 ↗
50. Viscosupplementation of the knee: Three cases of acute Pseudoseptic Arthritis with painful and irritating complications and a literature review10.5152/eurjrheum.2016.15075 ↗
51. Bilateral symmetric inflammatory reaction to hylan G-F 20 injection10.1002/1529-0131(200104)44:4<978::AID-ANR156>3.0.CO;2-N ↗
52. Degradation of the hyaluronic acid complex of synovial fluid by proteolytic enzymes and by ethylenediaminetetra-acetic acid10.1042/bj0720301 ↗
53. Comparison of poloxamer- and chitosan-based thermally sensitive gels for the treatment of vaginal mucositis10.3109/03639045.2012.762654 ↗
54. Thermogelling properties of purified poloxamer 40710.1016/j.heliyon.2017.e00390 ↗
55. Sosa, L., Calpena, A.C., Silva-Abreu, M., Espinoza, L.C., Rincon, M., Bozal, N., Domenech, O., Rodriguez-Lagunas, M.J., and Clares, B. (2019). Thermoreversible Gel-Loaded Amphotericin B for the Treatment of Dermal and Vaginal Candidiasis. Pharmaceutics, 11.10.3390/pharmaceutics11070312 ↗
56. Effect of carrageenan addition on the rennet-induced gelation of skim milk10.1002/jsfa.7620 ↗
57. Physicochemical stability, microrheological properties and microstructure of lutein emulsions stabilized by multilayer membranes consisting of whey protein isolate, flaxseed gum and chitosan10.1016/j.foodchem.2016.01.052 ↗
58. A Review of Poloxamer 407 Pharmaceutical and Pharmacological Characteristics10.1007/s11095-006-9104-4 ↗
59. Applications of poloxamers in ophthalmic pharmaceutical formulations: An overview10.1517/17425247.2013.796360 ↗
60. Rheology of joint fluid in total knee arthroplasty patients10.1016/S0736-0266(02)00050-5 ↗